gadolinium dtpa has been researched along with thromboplastin in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (thromboplastin) | Trials (thromboplastin) | Recent Studies (post-2010) (thromboplastin) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 10,540 | 281 | 2,126 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abendschein, DR; Chinen, LK; Fuhrhop, RW; Karukstis, KK; Lanza, GM; Scherrer, DE; Scott, MJ; Wickline, SA; Winter, PM; Yu, X | 1 |
1 other study(ies) available for gadolinium dtpa and thromboplastin
| Article | Year |
|---|---|
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Cell Membrane; Cells, Cultured; Contrast Media; Coronary Restenosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fluorine Compounds; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Oleic Acid; Oleic Acids; Paclitaxel; Particle Size; Swine; Thromboplastin | 2002 |